Ariez B.V.
Podcasts for the professional healthcare people
Ariez B.V.
Dr. Joshua Sabari
•
Ariez Publishing
Dr. Sabari shares the results of a phase I study of amivantamab and discusses what these results means for patients with metastatic non-small cell lung cancer (NSCLC) harbouring EGFR exon 20 insertion mutations.